1. In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC*-Au-SCSNMe2 and NHC*-Au-S-GLUC against advanced prostate cancer PC3. Issue 7 (August 2020) Authors: Walther, Wolfgang; Althagafi, Dhiyaa; Curran, Danielle; O'Beirne, Cillian; Mc Carthy, Cian; Ott, Ingo; Basu, Uttara; Büttner, Britta; Sterner-Kock, Anja; Müller-Bunz, Helge; Sánchez-Sanz, Goar; Zhu, Xiangming; Tacke, Matthias Journal: Anti-cancer drugs Issue: Volume 31:Issue 7(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Novel derivatives of the antibiotic NHC–Ag(I) drug candidate SBC3: Synthesis, biological evaluation and 109Ag NMR studies. (15th July 2018) Authors: O'Beirne, Cillian; Althani, Hessah T.; Dada, Oyinlola; Cassidy, Jennifer; Kavanagh, Kevin; Müller-Bunz, Helge; Ortin, Yannick; Zhu, Xiangming; Tacke, Matthias Journal: Polyhedron Issue: Volume 149(2018) Page Start: 95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The Antibacterial Drug Candidate SBC3 is a Potent Inhibitor of Bacterial Thioredoxin Reductase. (17th December 2020) Authors: O'Loughlin, Jennie; Napolitano, Silvia; Alkhathami, Fahad; O'Beirne, Cillian; Marhöfer, Daniel; O'Shaughnessy, Megan; Howe, Orla; Tacke, Matthias; Rubini, Marina Journal: Chembiochem Issue: Volume 22:Number 6(2021) Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The non‐isomorphous crystal structures of NHC—Au—Cl and NHC—Au—Br (NHC is 1, 3‐dibenzyl‐4, 5‐diphenylimidazol‐2‐ylidene). Issue 11 (6th October 2016) Authors: Tacke, Matthias; Dada, Oyinlola; O'Beirne, Cillian; Zhu, Xiangming; Müller-Bunz, Helge Journal: Acta crystallographica Issue: Volume 72:Issue 11(2016) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗